BioSpace News Archive

Business

Grunenthal and Mundipharma Enter Commercial Partnership in China

Gruenenthal and Mundipharma announced today that they have entered into a License and Distribution Agreement.

January 15, 2018
·
3 min read
Policy

Moberg Pharma Receives Favorable Outcome From NAD - Main Competitor to Discontinue Current Marketing

Moberg Pharma have received a positive outcome from the NAD regarding a challenge filed on Fungi-Nail, the largest U.S. competitor to the Kerasal Nail product.

January 15, 2018
·
3 min read
Business

amcure Appoints Biotech Executive Heinz Schwer to its Board

January 15, 2018
·
2 min read
FDA

BD, Check-Points Win CE Mark for Next-Generation Resistant Bacteria Screening Test

The new test provides diagnostic results up to 10 times faster than traditional tests.

January 15, 2018
·
5 min read
Google Backs Vaccitech’s $27M Series A Funding Round

Vaccitech is an Oxford University spinout company developing a universal flu vaccine, among other vaccine-related products.

January 15, 2018
·
3 min read
Deals

Nuvo Pharma (Ireland) Limited Acquires U.S. Product Rights to Resultz From Piedmont Pharma

Nuvo now owns all Resultz product and intellectual property rights throughout the world.

January 15, 2018
·
7 min read
Drug Development

Cingulate Therapeutics Presents New Data from its First in Human Proof of Concept Trial of CTX-1301 at the 2018 APSARD Annual Meeting

Overall, researchers found that CTX-1301 delivered consistent tri-modal release of the dexmethylphenidate hydrochloride.

January 15, 2018
·
4 min read
Biotech Bay

Ceterix Orthopaedics Awarded New Patent for Circumferential Suturing Method in Meniscus Repair

Ceterix’s new patent further protects the company’s unique products and methods that allow surgeons to arthroscopically pass suture through soft tissue in very tight joint compartments.

January 15, 2018
·
2 min read
Biotech Bay

10x Genomics Accelerates Plant and Animal Research with Supernova 2.0

10x Genomics today launched a new version of their de novo assembly solution to provide the fastest most cost-effective solution for creating high-quality de novo assemblies at scale for plants and animals.

January 15, 2018
·
3 min read
FDA

Teva Wins FDA Nod for TRISENOX (arsenic trioxide) Injection for First Line Treatment of Acute Promyelocytic Leukemia

The approval was based on a Priority Review by the FDA on data from published scientific literature and a review of Teva’s global safety database for arsenic trioxide.

January 15, 2018
·
11 min read